NCT00001251View on ClinicalTrials.gov

Phase I Study of Intrathecal Mafosfamide

PHASE1CompletedINTERVENTIONAL

Enrollment

65

Participants

Timeline

Start Date

November 30, 1989

Study Completion Date

November 30, 2003

Conditions

LeukemiaLymphomaMeningeal Neoplasm

Interventions

DRUG

Mafosfamide

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH